查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623502

全球除顫器市場規模（按最終用戶、產品、地區、範圍和預測）

Global Defibrillators Market Size By End User(Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets), By Product(Implantable Cardioverter Defibrillators (ICDS), External Defibrillators), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

去顫器市場規模及預測

2020 年，除顫器市場規模價值為 108.8 億美元，預計到 2028 年將達到 167.2 億美元，2021 年至 2028 年的複合年增長率為 5.60%。

老年人口的增加（老年人患目標疾病的風險最高）、心臟病發病率的上升以及對提供公共除顫器的日益關注，預計將在預測年內推動除顫器市場的發展。顫器市場將受到拖曳。全球除顫器市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

去顫器市場的定義

去顫器是一種電子設備，用於在無脈性室性心動過速、心律不整和心室顫動等嚴重情況下向患者心臟提供治療性電擊。電擊使心肌去極化，恢復正常的電脈衝。它可以預防患有危及生命的心律不整的人的猝死。除顫器的最終用戶包括醫院、診所、心臟中心、院前急救、公共市場、家庭保健和替代醫學市場。依產品不同，分為植入式心臟復律去顫器 (ICD)、體外去顫器、手動體外去顫器和可穿戴式心臟復律去顫器 (WCD)。

全球除顫器市場概況

老年人口的增加（目標疾病的風險最高）和對提供公共場所除顫器的日益關注預計將在預測幾年內推動除顫器市場的發展。此外，有關除顫器和心臟病發病率上升的培訓和宣傳計劃預計將在未來幾年推動市場發展。此外，CRT-D、S-ICD 和 MRI 相容 ICD 的開發也正在取得進展。

也有一些限制和課題阻礙了市場的成長。缺乏對心臟驟停（SCA）的認識和產品缺陷等因素可能成為市場發展的阻礙因素。

目錄

第 1 章：全球除顫器市場簡介

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章：經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第 4 章：全球除顫器市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析
  • 監理框架

第5章 全球除顫器市場（依最終用戶劃分）

  • 醫院、診所和心臟中心
  • 院前
  • 公共接取市場
  • 家庭醫療保健
  • 替代醫學市場
第6章 全球除顫器市場依產品類型
  • 植入式心臟復律去顫器 (ICD)
    • 植入式心臟復律去顫器 (T-ICD)
    • 皮下植入式心臟復律去顫器 (S-ICD)
  • 體外去顫器
    • 自動體外心臟去顫器 (AED)
  • 手動體外心臟去顫器
  • 穿戴式心臟復律去顫器 (WCD)

第7章 全球除顫器市場（按地區）

  • 概述
  • 2012 年至 2025 年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 2012 年至 2025 年歐洲市場估計與預測
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 2012 年至 2025 年亞太市場估計與預測
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 2012 年至 2025 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 2012 年至 2025 年世界其他地區市場估計與預測

第 8 章全球除顫器市場競爭格局

  • 概述
  • 公司市佔率
  • 供應商概況
  • 主要發展策略

第9章 公司簡介

  • Medtronic PLC
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Philips Healthcare
  • Zoll Medical Corporation
  • Biotronik Se & Co.Kg
  • Physio-Control International, Inc.
  • Cardiac Science Corporation
  • Sorin Group
  • Nihon Kohden Corporation

第10章 附錄

  • 關聯報告
簡介目錄
Product Code: 23941

Defibrillators Market Size And Forecast

Defibrillators Market size was valued at USD 10.88 Billion in 2020 and is projected to reachUSD 16.72 Billion by 2028, growing at aCAGR of 5.60% from 2021 to 2028.

The growing geriatric population having the highest risk of target diseases, rising incidence of cardiac diseases, and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. The Global Defibrillators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Defibrillators Market Definition

A defibrillator is an electronic device used to deliver a therapeutic shock to a patient's heart in serious conditions like pulseless ventricular tachycardia, cardiac arrhythmia, and ventricular fibrillation. The electric shock depolarizes the heart muscles and restores its normal electric impulse. It can prevent sudden death among people suffering from life-threatening arrhythmia. End-Users of defibrillators are Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. Based on the product, they are classified into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS).

Global Defibrillators Market Overview

The growing geriatric population having the highest risk of target diseases and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. Also, training & awareness programs on defibrillators and the rising incidence of cardiac diseases expects a boost to the market in the coming years. Additionally, the development of CRT-Ds, S-ICDs, and MRI-compatible ICDs

There are certain restraints and challenges faced which can hinder the market growth. Factors such as lack of awareness about the sudden cardiac arrest (SCA) and product failures are likely to act as market restraints.

Global Defibrillators Market: Segmentation Analysis

The Global Defibrillators Market is Segmented into End User, Product, And Geography.

Defibrillators Market by End-User

Hospitals, Clinics, & Cardiac Centers

Pre-Hospitals

Home Care

Alternate Care Markets

Based on the end-user, the market is bifurcated into Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. The Hospitals, Clinics, & Cardiac Centers segment is predicted to hold the largest market share. The factors can be attributed to the availability of reimbursements facilities and upsurge in the number of cardiac implant procedures.

Defibrillators Market by Product

Implantable Cardioverter Defibrillators (ICDS)

Implantable Cardioverter Defibrillators (T-ICDS)

Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)

Dual-Chamber ICDS

Single-Chamber ICDS

Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)

External Defibrillators

Automated External Defibrillators (AEDS)

Semi-Automated External Defibrillators

Fully Automated External Defibrillators

Manual External Defibrillators

Wearable Cardioverter Defibrillators (WCDS)

Based on the product, the market is bifurcated into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS). The Implantable Cardioverter Defibrillators (ICDS) segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) & S-ICD systems across the globe and the development of technologically advanced devices with extended longevity.

Defibrillators Market by Geography

Based on regional analysis, the Global Defibrillators Market is classified into

North America

Europe

Asia Pacific

Rest of the world

The largest share in the market will be dominated by North America owing to the technological advancements, increasing the geriatric population, and the prevalence of cardiac diseases in this region.

Key Players

The Major Players in the market are as follows:

  • Medtronic PLC
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Philips Healthcare (A Division of Koninklijke Philips N.V.)
  • Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
  • Biotronik Se & Co.Kg
  • Physio-Control International, Inc.
  • Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
  • orin Group (Now Livanova PLC)
  • Nihon Kohden Corporation

These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Key Developments

Product Launches and Product Expansions

  • On April 2020, Philips, a health technology company, announced that the Emergency Care and Resuscitation (ECR) business is recommencing the US manufacturing and shipping of external defibrillators. The company notified that the US Food and Drug Administration (FDA) had lifted the restrictions imposed on the manufacturing and distribution of defibrillators in the US.
  • On March 2021, The Rankin government announced that all public schools in Nova Scotia would be provided automated external defibrillators. The government invested USD 700,000. The purpose of this investment is the availability of these devices at the time of cardiac emergency.
  • On July 2021, ZOLL Medical Corporation announced that the company had received clearance from FDA 510(k) to release the TBI Dashboard feature on its Propaq M monitor and Propaq MD defibrillator. This feature provided clinical decision support for managing patients with TBI and was available in international markets, but it is now available in the U.S. market with the FDA clearance.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DEFIBRILLATORS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL DEFIBRILLATORS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 Global Defibrillators Market, By End User

  • 5.1 Hospitals, Clinics, & Cardiac Centers
  • 5.2 Pre-Hospitals
  • 5.3 Public Access Markets
  • 5.4 Home Care
  • 5.5 Alternate Care Markets

6 Global Defibrillators Market, By Product

  • 6.1 Implantable Cardioverter Defibrillators (ICDS)
    • 6.1.1 Implantable Cardioverter Defibrillators (T-ICDS)
    • 6.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
    • 6.1.1.2 Dual-Chamber ICDS
    • 6.1.1.3 Single-Chamber ICDS
    • 6.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
  • 6.2 External Defibrillators
    • 6.2.1 Automated External Defibrillators (AEDS)
    • 6.2.1.1 Semi-Automated External Defibrillators
    • 6.2.1.2 Fully Automated External Defibrillators
  • 6.3 Manual External Defibrillators
  • 6.4 Wearable Cardioverter Defibrillators (WCDS)

7 GLOBAL DEFIBRILLATORS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.5.1 Brazil
    • 7.5.2 Argentina
  • 7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 a€" 2025

8 GLOBAL DEFIBRILLATORS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Medtronic PLC
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 St. Jude Medical, Inc.
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Boston Scientific Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Philips Healthcare
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Zoll Medical Corporation
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Biotronik Se & Co.Kg
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Physio-Control International, Inc.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Cardiac Science Corporation
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Sorin Group
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Nihon Kohden Corporation
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Reports